Collagen-polymer conjugates
First Claim
Patent Images
1. A pharmaceutically acceptable, non-immunogenic composition comprising atelopeptide collagen chemically conjugated to a synthetic hydrophilic polymer.
5 Assignments
0 Petitions
Accused Products
Abstract
Collagen, particularly atelopeptide collagen, exhibits improved handling characteristics when chemically conjugated and/or crosslinked with a synthetic hydrophilic polymer.
887 Citations
33 Claims
- 1. A pharmaceutically acceptable, non-immunogenic composition comprising atelopeptide collagen chemically conjugated to a synthetic hydrophilic polymer.
-
14. A composition comprising:
collagen chemically conjugated to a synthetic hydrophilic polymer having a first end and a second end, said first end being bound to a collagen molecule, and said second end being bound to a growth factor. - View Dependent Claims (15, 16)
-
17. A pharmaceutically acceptable, non-immunogenic composition suitable for augmentation of soft tissue, which comprises:
-
atelopeptide collagen chemically conjugated to a synthetic hydrophilic polymer; and a sufficient amount of a fluid pharmaceutically acceptable carrier. - View Dependent Claims (18, 19, 20, 21, 22, 23, 24, 25, 26)
-
-
27. A pharmaceutically acceptable, non-immunogenic, injectable composition suitable for augmentation of soft tissue, which comprises:
-
atelopeptide collagen; a synthetic hydrophilic polymer having a first and second end, wherein said first and second ends comprise reactive groups capable of forming a covalent bond in situ with an available lysine side chain present in collagen; and a fluid pharmaceutically acceptable carrier in an amount sufficient to form an injectable composition. - View Dependent Claims (28, 29, 30, 31, 32, 33)
-
Specification